Basilea Pharmaceutica Ltd. (SIX: BSLN)

https://www.basilea.com

Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN). *

	Start	2000-10-01 splitoff
	Group	Basilea (Group)
	Predecessor	Roche (Group)
	Industry	antibiotic
	Industry 2	dermatic
	Person	Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)
	Person 2	Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries)

	Region	Allschwil BL
	Country	Switzerland
	Street	167b Hegenheimermattweg
	City	4123 Allschwil BL
	Tel	+41-61-606-1111
		Address record changed: 2024-04-07

Basic data	Employees	D: 101 to 500 (2021-12-31)
	Currency	CHF
	Annual sales	148,122,000 (revenue, total, consolidated (2021) 2021-12-31)
	Profit	-6,831,000 (2021-12-31)
	Cash	148,700,000 (2021-12-31)

		* Document for »About Section«: Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil.

		Record changed: 2024-12-29

Picture Berlin Partner Life Sciences Report 2024-2025 650x200px

More documents for Basilea (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)